Venlafaxine Hydrochloride Capsule, Extended Release
Product Images NDC 68788-8068
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Venlafaxine Hydrochloride (NDC 68788-8068). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Preferred Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure2 (Figure2)
Figure3 (Figure3)
This text provides recommendations for dosage adjustments of the drug Enlafaxine based on different patient groups with hepatic or renal impairment, CYP2D6 polymorphism, age, and gender. The recommended dosage adjustments are represented as reduction percentages and individualization of dosing may be necessary in some cases. The text also includes PK fold change and 90% Cl recommendations for special populations. Additionally, there is a graph showing change relative to the reference value.*
Logo1 (Logo1)
Logo2 (Logo2)
Venlafaxine HCl Extended-release Capsules 75mg (Venlafaxine Hydrochloride 75mg 30 Capsules)
This is a pharmaceutical label for Venlafaxine HCl Extended-Release Capsules, a generic version of Effexor ER. It contains 75mg of Venlafaxine and Hydrochloride, and it is manufactured by Camber Pharmaceuticals, Inc. The label provides instructions to not transfer this medication to anyone other than the individual for whom it was prescribed due to federal law regulations. Lot and batch numbers are also included for identification purposes.*
Venlafaxinestructure (Venlafaxinestructure)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.